Expert Opinion on Pharmacotherapy, Volume 16, Issue 6 (2015)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Pharmacotherapy, Volume 16, Issue 6 (2015)

See all volumes and issues
Vol 25, 2024 Vol 24, 2023 Vol 23, 2022 Vol 22, 2021 Vol 21, 2020 Vol 20, 2019 Vol 19, 2018 Vol 18, 2017 Vol 17, 2016 Volume 16, 2015 Vol 15, 2014 Vol 14, 2013 Vol 13, 2012 Vol 12, 2011 Vol 11, 2010 Vol 10, 2009 Vol 9, 2008 Vol 8, 2007 Vol 7, 2006 Vol 6, 2005 Vol 5, 2004 Vol 4, 2003 Vol 3, 2002 Vol 2, 2001 Vol 1, 1999-2000
Download citations Download PDFs Download issue

Editorial

Editorial
Smoldering multiple myeloma: to treat or not to treat
Massimo Gentile, Massimo Offidani, Ernesto Vigna, Laura Corvatta, Anna Grazia Recchia, Lucio Morabito, Massimo Martino, Fortunato Morabito & Silvia Gentili
Pages: 785-790
Published online: 08 Feb 2015
AbstractforSmoldering multiple myeloma: to treat or not to treat | Full Text | References | PDF (163.1 KB)
  • 2014 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access
Editorial
Alternative therapies to address the unmet medical needs of patients with phenylketonuria
Nenad Blau & Nicola Longo
Pages: 791-800
Published online: 07 Feb 2015
AbstractforAlternative therapies to address the unmet medical needs of patients with phenylketonuria | Full Text | References | PDF (298.8 KB)
  • 3488 Views
  • 37 CrossRef citations
  • 0Altmetric
Free Access
Editorial
Perspectives of fixed daily dose of sofosbuvir and ledipasvir for the treatment of chronic hepatitis C
Annarosa Floreani (Professor) MD
Pages: 801-804
Published online: 01 Mar 2015
AbstractforPerspectives of fixed daily dose of sofosbuvir and ledipasvir for the treatment of chronic hepatitis C | Full Text | References | PDF (124 KB)
  • 1019 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access

Original Research

Article
Prognostic factors for survival following initiation of second-line treatment with everolimus for metastatic renal cell carcinoma: evidence from a nationwide sample of clinical practice in the United States
Michael K Wong MD PhD, Eric Jonasch MD, Sumanta K Pal MD, James E Signorovitch PhD, Peggy L Lin PhD, Xufang Wang, Zhimei Liu PhD, Ken Culver MD, Jeffrey A Scott MD, Daniel J George & Nicholas J Vogelzang MD
Pages: 805-819
Published online: 12 Mar 2015
AbstractforPrognostic factors for survival following initiation of second-line treatment with everolimus for metastatic renal cell carcinoma: evidence from a nationwide sample of clinical practice in the United States | Full Text | References | PDF (507.8 KB) | Supplemental
  • 274 Views
  • 6 CrossRef citations
  • 0Altmetric

Review

In diabetic foot infections antibiotics are to treat infection, not to heal wounds
Mohamed Abbas MD, Ilker Uçkay MD & Benjamin A Lipsky MD
Pages: 821-832
Published online: 03 Mar 2015
AbstractforIn diabetic foot infections antibiotics are to treat infection, not to heal wounds | Full Text | References | PDF (279.1 KB)
  • 1446 Views
  • 90 CrossRef citations
  • 0Altmetric
Challenges in the development of new therapies for bronchiectasis
James D Chalmers, Michael Loebinger & Stefano Aliberti
Pages: 833-850
Published online: 24 Mar 2015
AbstractforChallenges in the development of new therapies for bronchiectasis | Full Text | References | PDF (486.9 KB)
  • 574 Views
  • 20 CrossRef citations
  • 0Altmetric
Systemic therapy for advanced pancreatic cancer: individualising cytotoxic therapy
Dearbhaile Catherine Collins (Specialist Registrar in Medical Oncology) MBBCh BAO MA PhD IMRCS MRCPI & Patrick Glyn Morris (Consultant in Medical Oncology) MBBCh BAO BMedSc MSc MD MRCPI
Pages: 851-861
Published online: 14 Mar 2015
AbstractforSystemic therapy for advanced pancreatic cancer: individualising cytotoxic therapy | Full Text | References | PDF (508.3 KB)
  • 506 Views
  • 8 CrossRef citations
  • 0Altmetric
Transdermal contraception methods: today’s patches and new options on the horizon
Anita L Nelson (Professor) MD
Pages: 863-873
Published online: 24 Mar 2015
AbstractforTransdermal contraception methods: today’s patches and new options on the horizon | Full Text | References | PDF (266.9 KB)
  • 604 Views
  • 7 CrossRef citations
  • 0Altmetric
Advances in pharmacotherapy for treating female sexual dysfunction
Rossella E Nappi (Professor) MD PhD & Laura Cucinella
Pages: 875-887
Published online: 02 Mar 2015
AbstractforAdvances in pharmacotherapy for treating female sexual dysfunction | Full Text | References | PDF (330.7 KB)
  • 1279 Views
  • 50 CrossRef citations
  • 0Altmetric
Intravesical therapy for bladder cancer
Sanjay G Patel (Fellow of Urologic Oncology) MD, Andrew Cohen (Urology Resident) MD, Adam B Weiner (Medical Student) BS & Gary D Steinberg (Professor of Surgery) MD
Pages: 889-901
Published online: 14 Mar 2015
AbstractforIntravesical therapy for bladder cancer | Full Text | References | PDF (318.1 KB)
  • 799 Views
  • 25 CrossRef citations
  • 0Altmetric
Changes and determination of dosing recommendations for medicinal products recently authorised in the European Union
Falk Ehmann, Marisa Papaluca, Francesca Di Giuseppe, Luca Pani, Andrea Eskova, Efthymios Manolis & Ralf Herold
Pages: 903-911
Published online: 14 Mar 2015
AbstractforChanges and determination of dosing recommendations for medicinal products recently authorised in the European Union | Full Text | References | PDF (216.9 KB)
  • 390 Views
  • 6 CrossRef citations
  • 0Altmetric

Drug Evaluation

Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps
Jean Bousquet, Claus Bachert, Jonathan Bernstein, G Walter Canonica, Warner Carr, Ronald Dahl, Pascal Demoly, Philippe Devillier, Peter Hellings, Wytske Fokkens, Ludger Klimek, Phil Lieberman, Eli Meltzer, David Price, Dermot Ryan & Ulrich Wahn
Pages: 913-928
Published online: 07 Mar 2015
AbstractforAdvances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps | Full Text | References | PDF (719.7 KB)
  • 667 Views
  • 27 CrossRef citations
  • 0Altmetric
ABT-450/ritonavir and ABT-267 in combination with ABT-333 for the treatment of hepatitis C virus
Ashley Arezou Minaei (Medical Student) MPH CPH & Kris V Kowdley (Director) (Clinical Professor of Medicine) MD FACP FAASLD
Pages: 929-937
Published online: 24 Mar 2015
AbstractforABT-450/ritonavir and ABT-267 in combination with ABT-333 for the treatment of hepatitis C virus | Full Text | References | PDF (212.3 KB)
  • 258 Views
  • 7 CrossRef citations
  • 0Altmetric

Erratum

Correction
Erratum
Page: 939
Published online: 16 Mar 2015
CitationforErratum | Full Text | PDF (31.3 KB)
  • 422 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Correction
Erratum
Page: 941
Published online: 15 Mar 2015
CitationforErratum | Full Text | PDF (27.9 KB)
  • 297 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Further Readings

Related articles
Page: 1
Published online: 24 Mar 2015
CitationforRelated articles | Full Text | PDF (86.9 KB)
  • 31 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

An update on the use of antihistamines in managing chronic urticaria
Yi-Kui Xiang et al.
Review Article | Published online: 30 Apr 2024
Open Access
The latest emerging drugs for the treatment of diabetic cardiomyopathy
Minghao Li et al.
Review Article | Published online: 30 Apr 2024
Pharmacotherapy for Gastrointestinal Angiodysplasia: is it effective?
Calvin M Johnson et al.
Editorial | Published online: 30 Apr 2024
Free Access
Current and emerging drugs for the treatment of pruritus: an update of the literature
Rami H. Mahmoud et al.
Review Article | Published online: 29 Apr 2024
View all latest articles